Patrick Salmon

After qualifying as a physician Patrick Salmon spent several years in clinical medicine later entering the area of clinical research.

While working for Contract Research Organisation in Ireland and the UK, Patrick organised and ran phase 1, 2, and 3 studies. After a short period working with a pharmaceutical company, he joined the Irish regulatory agency in 1994 and has worked there since, assessing medical aspects of all types of applications.

His areas of involvement include clinical trial assessment; mutual recognition and decentralised applications; and centralised applications.

In 2000, Patrick became a member of the Committee for Medicinal Products for Human Use (CHMP) at the European Medicines Agency (EMA). Later in 2004, he became an Irish delegate on the Committee for Orphan Medicinal Products (COMP) also at the EMA.

Additional interests include Product Information and he is Chair of the CHMP ad hoc group on the SmPC (Summary of Product Characteristics) and the CMD(h) (Co-ordination group for Mutual Recognition and Decentralised Procedures (human)) subgroup on harmonisation of the SmPC.

A voz das pessoas com doenças raras na EuropaEURORDIS A voz internacional das pessoas com doenças raras, Rare Diseases InternacionalRare Disease International Reúne doentes, famílias e especialistas para partilhar experiências num fórum multilinguístico. RareConnect O programa Rare Barometer é uma iniciativa da EURORDIS para a realização de inquéritos para transformar a experiência das pessoas com doenças raras em números e factos que podem ser partilhados com os responsáveis pela tomada de decisões.Rare Barometer An international awareness raising campaign taking place on the last day of February each year, Rare Disease Day is a EURORDIS initiativeRare Disease Day Adira ao maior encontro europeu das partes interessadas no âmbito das doenças raras na Conferência Bienal Europeia sobre Doenças Raras e Produtos Órfãos. A ECRD é uma iniciativa da EURORDISEuropean Conference on Rare Diseases